Skip to main content
OpenTrials

Clinical trial condition

Colitis, Ulcerative

Explore clinical trials studying Colitis, Ulcerative. Study availability and eligibility vary by location and protocol.

163 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Colitis, Ulcerative trial results

Completed

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06049017

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Clinnova Research Anaheim, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • Medical Associates Research Group, Inc. San Diego, California, United States
  • Peak Gastroenterology Associates Colorado Springs, Colorado, United States
View all 177 locations
View Trial Details
Completed

A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT05499130

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Teva Investigational Site 15568 Sun City, Arizona, United States
  • Teva Investigational Site 15556 San Diego, California, United States
  • Teva Investigational Site 15747 San Diego, California, United States
  • Teva Investigational Site 15357 Kissimmee, Florida, United States
View all 164 locations
View Trial Details
Completed

A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC

NCT05291689

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Clinical Study Site Tampa, Florida, United States
  • Clinical Study Site Lafayette, Louisiana, United States
  • Clinical Study Site Freehold, New Jersey, United States
  • Clinical Study Site Brooklyn, New York, United States
View all 17 locations
View Trial Details
Completed

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

NCT04989907

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +7 more
Locations
  • Kantonsspital St. Gallen Sankt Gallen, Canton of St. Gallen, Switzerland
  • Clarunis AG Basel, Switzerland
  • Bauchzentrum INSELSPITAL, Universitatsspital Bern Bern, Switzerland
  • Gastroenterologische Praxis Balsiger, Seibold & Partner Crohn-Colitis-Zentrum Bern, Switzerland
View Trial Details
Completed

A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

NCT04799496

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Soon Chunhyang University Hospital Bucheon Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Inje University Haeundae Paik Hospital Busan, South Korea
  • Good Gang-An Hospital Busan, South Korea
View all 43 locations
View Trial Details
Completed

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

NCT03648541

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Medical Research Center of Connecticut, LLC Hamden, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Columbia University Medical Center-New York Presbyterian Hospital New York, United States
View all 38 locations
View Trial Details
Completed

A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy

NCT03123120

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Aalborg Sygehus Syd Aalborg, Denmark
  • Sanos Clinic Herlev, Denmark
  • Odense University Hospital Odense, Denmark
  • Universitätsklinikum Erlangen Erlangen, Germany
View all 16 locations
View Trial Details
Completed

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

NCT03482635

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • Medical Research Center of Connecticut, LLC Hamden, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 54 locations
View Trial Details
Completed

This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients

NCT03100864

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +5 more
Locations
  • UZ Leuven Leuven, Belgium
  • Asklepios Kliniken Westklinikum Hamburg Hamburg, Germany
  • Universitätsklinikum Schleswig-Holstein, Campus Kiel Kiel, Germany
  • Addenbrooke's Hospital Cambridge, United Kingdom
View Trial Details
Completed

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03915769

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations
  • Local Institution - 104 Sapporo, Hokkaido, Japan
  • Local Institution - 105 Nishinomiya, Hyōgo, Japan
  • Local Institution - 156 Okayama, Okayama-ken, Japan
  • Local Institution - 153 Osaka, Japan
View all 67 locations
View Trial Details

Related conditions